M&T Bank’s Forte Biosciences FBRX Stock Holding History

M&T Bank’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-291	Closed	-$245K	–	1583
2021 Q2	$245K	Buy	+291	New	+$262K	﹤0.01%	1363

Other funds holding FBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

OQS

Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

M&T Bank's FBRX Position: Q3 2021 in Review

M&T Bank sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 291 shares — an estimated $245K sold.

M&T Bank first reported a position in FBRX in Q2 2021 and held it in 1 quarter. The position peaked at $245K in Q2 2021. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

M&T Bank reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
M&T Bank sold 291 Forte Biosciences shares in Q3 2021, an estimated $245K.
M&T Bank first reported a position in Forte Biosciences in Q2 2021 and held it in 1 quarter.
M&T Bank's Forte Biosciences position peaked at $245K in Q2 2021.
57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on M&T Bank's 13F filing for Q3 2021, filed 28 Oct 2021.